Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs DECIPHER LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA DECIPHER LABS GRANULES INDIA/
DECIPHER LABS
 
P/E (TTM) x 26.5 -2.1 - View Chart
P/BV x 3.7 0.6 575.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 GRANULES INDIA   DECIPHER LABS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
DECIPHER LABS
Mar-23
GRANULES INDIA/
DECIPHER LABS
5-Yr Chart
Click to enlarge
High Rs38163 605.2%   
Low Rs22714 1,615.7%   
Sales per share (Unadj.) Rs186.445.1 413.1%  
Earnings per share (Unadj.) Rs21.3-2.7 -803.8%  
Cash flow per share (Unadj.) Rs29.0-2.2 -1,297.4%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs116.423.0 506.5%  
Shares outstanding (eoy) m242.0410.10 2,396.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.60.9 191.1%   
Avg P/E ratio x14.2-14.5 -98.2%  
P/CF ratio (eoy) x10.5-17.3 -60.8%  
Price / Book Value ratio x2.61.7 155.9%  
Dividend payout %7.00-   
Avg Mkt Cap Rs m73,611389 18,918.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4,203412 1,021.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,119456 9,900.4%  
Other income Rs m14374 193.8%   
Total revenues Rs m45,262529 8,549.2%   
Gross profit Rs m9,133-106 -8,599.1%  
Depreciation Rs m1,8454 43,106.1%   
Interest Rs m5595 11,604.4%   
Profit before tax Rs m6,872-42 -16,522.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,706-15 -11,548.8%   
Profit after tax Rs m5,166-27 -19,261.6%  
Gross profit margin %20.2-23.3 -86.9%  
Effective tax rate %24.835.5 69.9%   
Net profit margin %11.4-5.9 -194.5%  
BALANCE SHEET DATA
Current assets Rs m25,741201 12,817.5%   
Current liabilities Rs m18,13550 36,592.0%   
Net working cap to sales %16.933.2 50.8%  
Current ratio x1.44.1 35.0%  
Inventory Days Days1430 48.0%  
Debtors Days Days77789 9.7%  
Net fixed assets Rs m23,29071 32,923.2%   
Share capital Rs m242101 239.6%   
"Free" reserves Rs m27,927131 21,303.6%   
Net worth Rs m28,169232 12,137.1%   
Long term debt Rs m1,4860-   
Total assets Rs m49,031272 18,054.1%  
Interest coverage x13.3-7.6 -174.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.91.7 54.8%   
Return on assets %11.7-8.1 -144.1%  
Return on equity %18.3-11.6 -158.7%  
Return on capital %25.1-15.8 -158.1%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Exports (fob) Rs m36,526NA-   
Imports (cif) Rs m14,120NA-   
Fx inflow Rs m36,5260-   
Fx outflow Rs m14,1200-   
Net fx Rs m22,4060-   
CASH FLOW
From Operations Rs m7,387-16 -47,204.4%  
From Investments Rs m-1,914-43 4,475.3%  
From Financial Activity Rs m-4,403-22 20,478.6%  
Net Cashflow Rs m1,068-80 -1,337.0%  

Share Holding

Indian Promoters % 41.6 0.0 -  
Foreign collaborators % 0.4 16.4 2.1%  
Indian inst/Mut Fund % 28.9 0.0 -  
FIIs % 18.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 83.6 69.5%  
Shareholders   190,691 34,511 552.6%  
Pledged promoter(s) holding % 4.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs COMBAT DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs COMBAT DRUGS Share Price Performance

Period GRANULES INDIA COMBAT DRUGS S&P BSE HEALTHCARE
1-Day 0.41% 1.09% 1.24%
1-Month -6.16% -17.29% -0.69%
1-Year 59.24% -0.67% 61.92%
3-Year CAGR 11.76% -24.01% 18.18%
5-Year CAGR 29.94% -10.76% 19.80%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the COMBAT DRUGS share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of COMBAT DRUGS the stake stands at 16.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of COMBAT DRUGS.

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

COMBAT DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of COMBAT DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.